Based on the STRATA Skin Sciences Inc stock forecast from 1 analysts, the average analyst target price for STRATA Skin Sciences Inc is USD 6.00 over the next 12 months. STRATA Skin Sciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of STRATA Skin Sciences Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, STRATA Skin Sciences Inc’s stock price was USD 2.65. STRATA Skin Sciences Inc’s stock price has changed by +7.72% over the past week, +4.74% over the past month and -32.67% over the last year.
No recent analyst target price found for STRATA Skin Sciences Inc
No recent average analyst rating found for STRATA Skin Sciences Inc
Company Overview STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Read Less
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates in two se...Read More
Frequently Asked Questions About STRATA Skin Sciences Inc (SSKN) Stock
Based on ratings from 1 analysts STRATA Skin Sciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on SSKN's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for SSKN is USD 6.00 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 6.
SSKN stock's Price/Earning ratio is 0.80.
Our analysis grades SSKN stock's Price / Earning ratio at C-. This means that SSKN stock's Price/Earning ratio is above 29% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this SSKN may be undervalued for its sector.
The last closing price of SSKN's stock was USD 2.65.
The most recent market capitalization for SSKN is USD 0.01B.
Based on targets from 1 analysts, the average taret price for SSKN is projected at USD 6.00 over the next 12 months.
This means that SSKN's stock price may go up by +126.42% over the next 12 months.
We can't find any ETFs which contains STRATA Skin Sciences Inc's stock.
As per our most recent records STRATA Skin Sciences Inc has 106 Employees.
STRATA Skin Sciences Inc's registered address is 5 Walnut Grove Drive, Horsham, PA, United States, 19044.
You can get more information about it from STRATA Skin Sciences Inc's website at https://www.strataskinsciences.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About STRATA Skin Sciences Inc (SSKN) Stock
Based on ratings from 1 analysts STRATA Skin Sciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on SSKN's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for SSKN is USD 6.00 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 6.
SSKN stock's Price/Earning ratio is 0.80.
Our analysis grades SSKN stock's Price / Earning ratio at C-. This means that SSKN stock's Price/Earning ratio is above 29% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this SSKN may be undervalued for its sector.
The last closing price of SSKN's stock was USD 2.65.
The most recent market capitalization for SSKN is USD 0.01B.
Based on targets from 1 analysts, the average taret price for SSKN is projected at USD 6.00 over the next 12 months.
This means that SSKN's stock price may go up by +126.42% over the next 12 months.
We can't find any ETFs which contains STRATA Skin Sciences Inc's stock.
As per our most recent records STRATA Skin Sciences Inc has 106 Employees.
STRATA Skin Sciences Inc's registered address is 5 Walnut Grove Drive, Horsham, PA, United States, 19044.
You can get more information about it from STRATA Skin Sciences Inc's website at https://www.strataskinsciences.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SSKN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
